HBM Healthcare Investments AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of HBM Healthcare Investments AG generated cash of -$1,705,000, which is less than the previous year. Cash used in financing activities reached the amount of -$118,800,000 last year. Net change in cash is therefore $4,495,000.
Cash Flow
| 2010 | -16.42M | 186.90M | -103.63M |
|---|---|---|---|
| 2011 | -17.17M | 148.90M | -105.82M |
| 2012 | -14.06M | -39.90M | -61.72M |
| 2016 | 23.08M | 11.92M | 20.29M |
| 2018 | 115.87M | 60M | -56.44M |
| 2020 | -4.15M | 60M | -54.45M |
| 2021 | -3.22M | 59M | -55.83M |
| 2023 | -1.28M | 71.5M | -69.86M |
| 2024 | -1.70M | 125M | -118.8M |
HBMN.SW Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.73M | 5.38M | 6.09M | 4.70M | 6.11M | 140.38M | 155.43M | 129.08M | 65.60M |
Operating activities | |||||||||
Net income | -1.08M | -146.31M | 756.27M | 182.69M | 115.87M | 23.08M | 0 | 0 | 0 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -1.70M | -1.28M | -3.22M | -4.15M | 115.87M | 23.08M | -14.06M | -17.17M | -16.42M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -491.79M | -139.73M | -64.58M | -68.86M |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | -329K | -116K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 316K |
Cash generated by investing activities | 125M | 71.5M | 59M | 60M | 60M | 11.92M | -39.90M | 148.90M | 186.90M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 4.81M | 4.40M | 11.24M |
Payments for dividends | 0 | 0 | 0 | 0 | -40.78M | -42.27M | 0 | 0 | 0 |
Repurchases of common stock | -66.49M | -67.48M | -53.57M | -52.17M | -13.38M | -34.01M | -33.54M | -26.45M | -29.95M |
Repayments of term debt | -50M | 0 | 0 | 0 | 0 | 68.79M | -30M | -77.66M | 0 |
Cash used in financing activities | -118.8M | -69.86M | -55.83M | -54.45M | -56.44M | 20.29M | -61.72M | -105.82M | -103.63M |
Net Change In Cash | 4.49M | 344K | -63K | 1.39M | 407K | -35.55M | -114.21M | 26.70M | 63.47M |
Cash at end of period | 10.22M | 5.73M | 6.03M | 6.09M | 6.52M | 104.82M | 41.22M | 155.78M | 129.08M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |